As reported, aldehyde dehydrogenase 1A1 (ALDH1A1) can serve as a marker for glioma stem cells; moreover, ALDH1A1+ cells were increased in the invasive frontier area compared with the non-invasive frontier area [43]. This evidence concerns the gene ALDH1A1 and central nervous system cancer.